Company Filing History:
Years Active: 2020
Title: Christoph Kneip: Innovator in Tumor Molecular Subtyping
Introduction
Christoph Kneip is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of cancer research, particularly in the molecular subtyping of tumors. His work aims to improve the treatment and stratification of cancer patients based on their tumor characteristics.
Latest Patents
Kneip holds a patent for "Methods and kits for the molecular subtyping of tumors." This invention relates to an in vitro method of identifying a molecular subtype of a tumor in a cancer patient. It also includes a method for stratifying a cancer patient for tumor treatment. Additionally, the patent encompasses kits that are useful for identifying a molecular subtype of a tumor in a cancer patient. He has 1 patent to his name.
Career Highlights
Throughout his career, Christoph Kneip has worked with prominent companies in the biotechnology sector. Notably, he has been associated with BioNTech Diagnostics GmbH and Stratifyer Molecular Pathology GmbH. His experience in these organizations has allowed him to contribute to advancements in molecular pathology and cancer diagnostics.
Collaborations
Kneip has collaborated with various professionals in his field, including Ralph Markus Wirtz. Their joint efforts have furthered research and development in tumor molecular subtyping.
Conclusion
Christoph Kneip's innovative work in the molecular subtyping of tumors represents a significant advancement in cancer treatment. His contributions through patents and collaborations continue to impact the field positively.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.